TERN
Price
$5.86
Change
-$0.19 (-3.14%)
Updated
Dec 20 closing price
99 days until earnings call
VYNE
Price
$2.50
Change
+$0.11 (+4.60%)
Updated
Dec 20, 04:59 PM (EDT)
Ad is loading...

TERN vs VYNE

Header iconTERN vs VYNE Comparison
Open Charts TERN vs VYNEBanner chart's image
Terns Pharmaceuticals
Price$5.86
Change-$0.19 (-3.14%)
Volume$4.75M
CapitalizationN/A
VYNE Therapeutics
Price$2.50
Change+$0.11 (+4.60%)
Volume$276
CapitalizationN/A
TERN vs VYNE Comparison Chart
Loading...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TERN vs. VYNE commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TERN is a Hold and VYNE is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (TERN: $5.86 vs. VYNE: $2.50)
Brand notoriety: TERN and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TERN: 284% vs. VYNE: 34%
Market capitalization -- TERN: $498.59M vs. VYNE: $37.62M
TERN [@Biotechnology] is valued at $498.59M. VYNE’s [@Biotechnology] market capitalization is $37.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TERN’s FA Score shows that 0 FA rating(s) are green whileVYNE’s FA Score has 1 green FA rating(s).

  • TERN’s FA Score: 0 green, 5 red.
  • VYNE’s FA Score: 1 green, 4 red.
According to our system of comparison, VYNE is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TERN’s TA Score shows that 4 TA indicator(s) are bullish while VYNE’s TA Score has 3 bullish TA indicator(s).

  • TERN’s TA Score: 4 bullish, 6 bearish.
  • VYNE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both TERN and VYNE are a bad buy in the short-term.

Price Growth

TERN (@Biotechnology) experienced а -12.93% price change this week, while VYNE (@Biotechnology) price change was -2.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

TERN is expected to report earnings on Apr 01, 2025.

VYNE is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TERN($499M) has a higher market cap than VYNE($37.6M). VYNE YTD gains are higher at: 7.296 vs. TERN (-9.707). VYNE has higher annual earnings (EBITDA): -37.7M vs. TERN (-99.08M). TERN has more cash in the bank: 373M vs. VYNE (70.2M). VYNE has less debt than TERN: VYNE (123K) vs TERN (1.31M). VYNE has higher revenues than TERN: VYNE (493K) vs TERN (0).
TERNVYNETERN / VYNE
Capitalization499M37.6M1,327%
EBITDA-99.08M-37.7M263%
Gain YTD-9.7077.296-133%
P/E RatioN/A0.78-
Revenue0493K-
Total Cash373M70.2M531%
Total Debt1.31M123K1,061%
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TERNVYNE
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Ad is loading...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSJRX65.520.98
+1.52%
Cohen & Steers Realty Shares R
EMCAX66.590.48
+0.73%
Empiric Class A
SCAVX14.580.08
+0.55%
AB Small Cap Value A
NWHLX9.19N/A
N/A
Nationwide Bailard Intl Eqs M
GSIKX17.49-0.01
-0.06%
Goldman Sachs International Eq Inc Instl

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with FATE. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
+4.60%
FATE - VYNE
33%
Loosely correlated
+1.20%
VTGN - VYNE
32%
Poorly correlated
+11.11%
TRDA - VYNE
30%
Poorly correlated
+1.79%
TERN - VYNE
29%
Poorly correlated
-3.14%
OBIO - VYNE
29%
Poorly correlated
+2.50%
More